Today: Treatment.
Duke University Hospital has announced it is part of the first national study of a drug the World Health Organization has called "the only drug right now that we think may have real efficacy" to treat COVID-19.
That drug is Remdesivir. It was first developed at UNC-Chapel Hill's Gillings School of Global Public Health.
WUNC reporter Jay Price speaks to Dr. Cameron Wolfe, associate professor of medicine at Duke University and the lead investigator in the new study, about the Remdesivir trial and its prospects for treating COVID-19.
